51786-11-9

Basic information

• Product Name: Benzonitrile, 2-chloro-3-hydroxy-
• Synonyms: Benzonitrile, 2-chloro-3-hydroxy-;2 - chloro - 3 - cyanophenol
• CAS NO: 51786-11-9
• Molecular Formula: C₇H₄ClNO
• Molecular Weight: 153.57
• Mol File: 51786-11-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 273.7±25.0 °C(Predicted)
• Appearance: /
• Density: 1.41±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 7.11±0.10(Predicted)
• CAS DataBase Reference: Benzonitrile, 2-chloro-3-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 2-chloro-3-hydroxy-(51786-11-9)
• EPA Substance Registry System: Benzonitrile, 2-chloro-3-hydroxy-(51786-11-9)

Safety Data

• Hazardous Substances Data: 51786-11-9(Hazardous Substances Data)

Usage

General Description

Benzonitrile, 2-chloro-3-hydroxy- is a chemical compound with the molecular formula C7H4ClNO. It is a derivative of benzonitrile, also known as 2-chloro-3-cyanophenol. Benzonitrile, 2-chloro-3-hydroxy- is a colorless to pale yellow solid with a molecular weight of 153.566 g/mol. It is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, as well as in the production of dyes and other organic compounds. It is also known to have biological activity, particularly as an anti-cancer agent and as an inhibitor of tyrosine-protein kinases. However, it is important to handle and use this chemical with caution, as it may have harmful effects on human health and the environment if not properly managed.

Upstream product

• 56962-10-8 2-chloro-3-hydroxybenzaldehyde 
• 853331-52-9 2-chloro-3-methoxybenzonitrile 
• 129298-23-3 3-hydroxy-2-nitrobenzonitrile 
• 873-62-1 m-cyanophenol 
• 211172-52-0 2-amino-3-hydroxybenzonitrile 

Downstream Products

• 1227416-17-2 C₁₉H₁₂ClN₅O₂ 
• 1338327-04-0 2-chloro-3-cyanophenyl trifluoromethanesulfonate 

Relevant articles and documents

4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

Substituted triazole derivatives as oxytocin antagonists

The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.